1100873-13-9

Basic information

• Product Name: (3-(2-methoxy-5-trifluoromethoxyphenyl)-6-chloropyrazin-2-yl)[(4-methoxyphenyl)methyl]amine
• Synonyms: (3-(2-methoxy-5-trifluoromethoxyphenyl)-6-chloropyrazin-2-yl)[(4-methoxyphenyl)methyl]amine
• CAS NO: 1100873-13-9
• Molecular Weight: 439.821
• Mol File: 1100873-13-9.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: (3-(2-methoxy-5-trifluoromethoxyphenyl)-6-chloropyrazin-2-yl)[(4-methoxyphenyl)methyl]amine(CAS DataBase Reference)
• NIST Chemistry Reference: (3-(2-methoxy-5-trifluoromethoxyphenyl)-6-chloropyrazin-2-yl)[(4-methoxyphenyl)methyl]amine(1100873-13-9)
• EPA Substance Registry System: (3-(2-methoxy-5-trifluoromethoxyphenyl)-6-chloropyrazin-2-yl)[(4-methoxyphenyl)methyl]amine(1100873-13-9)

Safety Data

• Hazardous Substances Data: 1100873-13-9(Hazardous Substances Data)

Upstream product

• 584-08-7 potassium carbonate 
• 290832-43-8 2-methoxy-5-trifluoromethoxybenzeneboronic acid 

Relevant articles and documents

SUBSTITUTED ARYLPYRAZINES

Arylpyrazine compounds are provided, including arylpyrazines that can bind with high affinity and high selectivity to CRF1 receptors, including human CRF1 receptors. The invention thus includes methods for treatment of disorders and diseases associated with CRF1 receptors, including CNS-related disorders and diseases, particularly affective disorders and diseases, and acute and chronic neurological disorders and diseases.